[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Fresenius Medical Care Ag ADR (FMS)

Fresenius Medical Care Ag ADR (FMS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 12,083,760
  • Shares Outstanding, K 540,177
  • Annual Sales, $ 22,207 M
  • Annual Income, $ 1,107 M
  • EBIT $ 2,053 M
  • EBITDA $ 3,751 M
  • 60-Month Beta 0.80
  • Price/Sales 0.54
  • Price/Cash Flow 4.00
  • Price/Book 0.72

Options Overview Details

View History
  • Implied Volatility 58.91% (+14.63%)
  • Historical Volatility 46.94%
  • IV Percentile 29%
  • IV Rank 24.80%
  • IV High 163.32% on 02/11/26
  • IV Low 24.48% on 05/21/26
  • Expected Move (DTE 5) 1.19 (5.17%)
  • Put/Call Vol Ratio 0.16
  • Today's Volume 1,286
  • Volume Avg (30-Day) 178
  • Put/Call OI Ratio 0.63
  • Today's Open Interest 3,432
  • Open Int (30-Day) 3,135
  • Expected Range 21.83 to 24.21

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year $0.52
  • Growth Rate Est. (year over year) +192,015.38%

Price Performance

See More
Period Period Low Period High Performance
1-Month
20.55 +12.02%
on 06/02/26
23.06 -0.15%
on 06/12/26
+0.78 (+3.51%)
since 05/12/26
3-Month
20.02 +14.99%
on 05/05/26
23.84 -3.44%
on 04/10/26
+0.27 (+1.19%)
since 03/12/26
52-Week
20.02 +14.99%
on 05/05/26
28.96 -20.51%
on 06/16/25
-5.92 (-20.46%)
since 06/12/25

Most Recent Stories

More News
Fresenius Medical Care launches kinexus worldwide, a unified digital platform to support home dialysis

BAD HOMBURG, Germany , June 3, 2026 /PRNewswire/ -- Fresenius Medical Care, the world's leading provider of products and services for individuals with renal diseases, today announced the global launch...

FMS : 23.02 (+2.91%)
Fresenius Medical Care launches first tranche of its share buyback program of up to EUR 600 million

BAD HOMBURG, Germany , May 28, 2026 /PRNewswire/ -- Fresenius Medical Care (FME), the world's leading provider of products and services for individuals with renal diseases, today announced the launch...

FMS : 23.02 (+2.91%)
Fresenius Medical Care highlights new renal research and innovation at ERA Congress 2026

BAD HOMBURG, Germany , May 27, 2026 /PRNewswire/ -- Fresenius Medical Care (FME), the world's leading provider of products and services for individuals with kidney diseases, presents new research...

FMS : 23.02 (+2.91%)
Fresenius Medical Care announces new share buyback program with a total volume of around EUR 1 billion with phased execution over 12 months

BAD HOMBURG, Germany , May 26, 2026 /PRNewswire/ -- Fresenius Medical Care (FME), the world's leading provider of products and services for individuals with renal diseases, intends to execute a new...

FMS : 23.02 (+2.91%)
Fresenius Medical Care Annual General Meeting: Strengthening performance and advancing innovation in kidney care

BAD HOMBURG, Germany , May 21, 2026 /PRNewswire/ -- Fresenius Medical Care (FME), the world's leading provider of products and services for individuals with renal diseases, has completed a milestone...

FMS : 23.02 (+2.91%)
Fresenius Medical Care Reappoints Chief Financial Officer Martin Fischer

BAD HOMBURG, Germany , May 20, 2026 /PRNewswire/ -- The Supervisory Board of Fresenius Medical Care AG, the world's leading provider of products and services for individuals with renal disease,...

FMS : 23.02 (+2.91%)
Fresenius Medical Care delivers strong operating income growth in Q1 2026 while advancing the U.S. rollout of 5008X CAREsystems at speed

BAD HOMBURG, Germany , May 5, 2026 /PRNewswire/ -- "Fresenius Medical Care delivered continued operational and financial progress in the first quarter, with organic revenue growth, improved profitability...

FMS : 23.02 (+2.91%)
Fresenius Medical Care's Profitability Streak Meets the HDF Rollout Reality Check

Barchart Research What to Expect from FMS Earnings FMS Generated May 4, 2026 Current Price $22.65 EPS Estimate $$0.59 Consensus Rating Hold Average Move 4.55% Fresenius Medical Care's Profitability Streak...

FMS : 23.02 (+2.91%)
DaVita Stock: Is DVA Outperforming the Health Care Sector?

DaVita has outperformed the Health Care sector recently, but analysts are cautious about the stock’s prospects.

XLV : 153.81 (-0.18%)
FMS : 23.02 (+2.91%)
DVA : 208.66 (+2.37%)
Fresenius Medical Care delivers 27% earnings growth in 2025 and reaches upper end of its financial outlook; margin within 2025 mid-term target band

BAD HOMBURG, Germany , Feb. 24, 2026 /PRNewswire/ -- "Fresenius Medical Care closed a milestone year marked by outstanding profitability gains. Over the past three years, we built a stronger and...

FMS : 23.02 (+2.91%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 32% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Fresenius Medical Care AG & Co. KGaA is one of the largest integrated providers of products and services for individuals undergoing dialysis. Fresenius Medical provides products and services across the entire dialysis value chain throughout the World. Fresenius Medical manufactures a variety of durable...

See More

Key Turning Points

3rd Resistance Point 23.41
2nd Resistance Point 23.23
1st Resistance Point 23.13
Last Price 23.02
1st Support Level 22.84
2nd Support Level 22.67
3rd Support Level 22.56

See More

52-Week High 28.96
Fibonacci 61.8% 25.54
Fibonacci 50% 24.49
Fibonacci 38.2% 23.44
Last Price 23.02
52-Week Low 20.02

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.